375 related articles for article (PubMed ID: 12502848)
1. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS
J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
3. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
[TBL] [Abstract][Full Text] [Related]
4. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.
Devergne O; Cahir McFarland ED; Mosialos G; Izumi KM; Ware CF; Kieff E
J Virol; 1998 Oct; 72(10):7900-8. PubMed ID: 9733827
[TBL] [Abstract][Full Text] [Related]
5. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
[TBL] [Abstract][Full Text] [Related]
6. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
Fries KL; Miller WE; Raab-Traub N
Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141
[TBL] [Abstract][Full Text] [Related]
7. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
[TBL] [Abstract][Full Text] [Related]
8. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production.
Eliopoulos AG; Gallagher NJ; Blake SM; Dawson CW; Young LS
J Biol Chem; 1999 Jun; 274(23):16085-96. PubMed ID: 10347160
[TBL] [Abstract][Full Text] [Related]
9. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
Eliopoulos AG; Young LS
Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
[TBL] [Abstract][Full Text] [Related]
10. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling.
Xie P; Hostager BS; Munroe ME; Moore CR; Bishop GA
J Immunol; 2006 May; 176(9):5388-400. PubMed ID: 16622006
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
12. LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2.
Kieser A; Kaiser C; Hammerschmidt W
EMBO J; 1999 May; 18(9):2511-21. PubMed ID: 10228165
[TBL] [Abstract][Full Text] [Related]
13. Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression.
Miller WE; Cheshire JL; Raab-Traub N
Mol Cell Biol; 1998 May; 18(5):2835-44. PubMed ID: 9566902
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.
Siegler G; Kremmer E; Gonnella R; Niedobitek G
Mol Pathol; 2003 Jun; 56(3):156-61. PubMed ID: 12782762
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
Kilger E; Kieser A; Baumann M; Hammerschmidt W
EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
[TBL] [Abstract][Full Text] [Related]
16. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
17. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
[TBL] [Abstract][Full Text] [Related]
18. Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms.
Busch LK; Bishop GA
J Immunol; 2001 Nov; 167(10):5805-13. PubMed ID: 11698454
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).
Arcipowski KM; Stunz LL; Graham JP; Kraus ZJ; Vanden Bush TJ; Bishop GA
J Biol Chem; 2011 Mar; 286(12):9948-55. PubMed ID: 21262968
[TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.
Izumi KM; Cahir McFarland ED; Ting AT; Riley EA; Seed B; Kieff ED
Mol Cell Biol; 1999 Aug; 19(8):5759-67. PubMed ID: 10409763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
